Skip Navigation Links
Centers for Disease Control and Prevention


 CDC Home Search Health Topics A-Z
 
National Center for Chronic Disease Prevention and Health Promotion
  Cancer Prevention and Control - Monitoring - Research - Public Health Programs - Education
Cancer Home | About Us | Events | En Espaρol | Site Map | Contact Us
   
 

•

 

•

 

•

   
 

•

 

•

 

•

 

•

 

•

 

•


Photos of men  Prostate Cancer Control Initiatives Prostate Cancer Awareness logo
Through prostate cancer control initiatives, CDC provides the public, physicians, and policymakers with the information they need to make informed decisions about the potential risks and benefits of prostate cancer screening and follow-up.
Highlights
 Informed Decision Making: A Personal Health Care Choice Spotlight!
 Shared Decision Making: Communication Between Patients and Health Care Professionals
 U.S. Preventive Services Task Force (USPSTF) Guidelines on Screening

 Informed Decision Making: A Personal Health Care Choice Spotlight!
Informed decision making occurs when an individual understands the nature and risks of prostate cancer; the risks, benefits, and alternatives to screening; participates in decision making at a level he desires; and makes a decision consistent with his preferences and values, or defers the decision to a later time. For more information, visit the Spotlight on Prostate Cancer Screening: Informed Decision Making.

 Shared Decision Making: Communication Between Patients and Health Care Professionals
Shared decision making is a process carried out between a patient and his health care professional in the clinical setting where both parties share information and the patient understands the nature and risks of prostate cancer; the risks, benefits and alternatives to screening; participates in decision making at a level he desires; and makes a decision consistent with his preferences and values, or defers the decision to a later time. For more information, visit Screening for Prostate Cancer: Sharing the Decision Toolkit.

 U.S. Preventive Services Task Force (USPSTF) Guidelines on Screening
USPSTF found good evidence that prostate specific antigen (PSA) screening can detect early-stage prostate cancer but found mixed and inconclusive evidence that early detection improves health outcomes. USPSTF concluded that evidence is insufficient to determine whether the benefits outweigh the risks for a screened population.

CDC supports USPSTF's position on prostate cancer screening, as well as promotes informed decision-making. CDC also provides many resource materials for consumers, public health professionals, and health care providers to assist in informed and shared decision-making regarding prostate cancer screening.


 2004 Cancer  Burden Data

•

Prostate cancer is the most common form of cancer among U.S. men, after skin cancer

•

About 230,110 new cases will be diagnosed

•

Approximately 29,900 men will die of prostate cancer


Privacy Policy | Accessibility

Cancer Home | About DCPC | Events | En Espaρol | Site Map | Contact Us

CDC Home | Search | Health Topics A-Z

Page last reviewed: Wednesday, October 13, 2004

United States Department of Health and Human Services
Centers for Disease Control and Prevention
National Center for Chronic Disease Prevention and Health Promotion
Division of Cancer Prevention and Control